Advertisement
Personnel News
Subscribe to Personnel News

The Lead

Auxilium Pharma to Cut Workforce by 30%

September 10, 2014 8:15 am | News | Comments

Auxilium Pharmaceuticals said Tuesday it is cutting 30 percent of its workforce, about 190 jobs, as part of a restructuring of its operations that will save it at least $75 million a year.           

EMD Serono Appoints New Senior Vice President, Neurology and Immunology

September 2, 2014 9:09 am | News | Comments

EMD Serono announced today that Drew Young has joined the company as Senior Vice President,...

DuPont Fined $1.3M Over Series of West Virginia Chemical Leaks

August 28, 2014 8:20 am | by JOHN RABY, Associated Press | News | Comments

DuPont will pay a fine of $1.275M to settle a federal complaint over eight chemical releases...

Moberg Pharma’s Head of U.S. Operations to Resign by End of January 2015

August 28, 2014 8:13 am | News | Comments

Moberg Pharma AB today announced that its head of U.S. operations, Steve Cagle, has announced...

View Sample

FREE Email Newsletter

That’s Nice Announces Expanded Offering For Strategic Content And Public Relations

August 26, 2014 11:02 am | News | Comments

That’s Nice LLC, a research-focused strategic marketing agency dedicated to life science markets, today announced the formation of a new dedicated team that will support clients with comprehensive strategic content development.    

PPD Names New Executive Vice President and Chief Financial Officer

August 26, 2014 9:01 am | News | Comments

Pharmaceutical Product Development, LLC (PPD) today announced the appointment of Robert Hureau as executive vice president and chief financial officer. Hureau brings 25 years of experience and extensive financial expertise spanning the medical technology/life sciences, manufacturing and consumer sectors.

Donald Johns Joins Biogen Idec to Lead ALS Innovation Hub

August 26, 2014 8:06 am | News | Comments

Biogen Idec announced that Donald R. Johns, M.D., has joined the company as vice president, leading Biogen Idec’s amyotrophic lateral sclerosis (ALS) Innovation Hub (ALS iHub).             

Advertisement

Eli Lilly to Close Terre Haute Animal Enzyme Plant

August 14, 2014 8:02 am | News | Comments

Eli Lilly and Co. says it will close its Elanco animal enzyme plant in Terre Haute by early 2016 as part of a consolidation push. Lilly spokesman Ed Sagebiel tells the Tribune-Star the Indianapolis-based company is consolidating all of its animal enzyme manufacturing to a site in Great Britain.

GE Healthcare Appoints General Manager of Asia Commercial BioProcess

August 13, 2014 8:40 am | News | Comments

GE Healthcare Life Sciences today announced the appointment of Olivier Loeillot as General Manager, Asia Commercial for BioProcess.  In this newly-created role Olivier will oversee commercial activities in the fast-moving Asian market for GE Healthcare Life Science’s rapidly growing BioProcess business.

BioProcess Technology Consultants Promotes Two to Principal Consultants

August 11, 2014 9:14 am | News | Comments

Bioprocess Technology Consultants, Inc. (BPTC), a technical, and regulatory consulting company for the global biopharmaceutical industry, has promoted Susan Dana Jones, Ph.D., and Thomas C. Ransohoff to Principal Consultants.     

Astellas Hires Industry Veteran to Head of Corporate and Employee Communications

July 31, 2014 10:01 am | News | Comments

Astellas has appointed Moyra Knight as the head of corporate and employee communications in the Americas region. Knight will report directly to Jeff Winton, senior vice president, chief communications officer.       

Dendreon Names New President and Chief Executive Officer

July 30, 2014 4:06 pm | News | Comments

Dendreon Corporation announced that its board of directors has appointed W. Thomas Amick as president and chief executive officer, effective immediately. Mr. Amick has also been appointed to the company’s board of directors.     

Advertisement

Amgen Laying Off at Least 2,400

July 30, 2014 7:56 am | by LINDA A. JOHNSON, AP Business Writer | News | Comments

Amgen said it will lay off 12 to 15 percent of its worldwide workforce and close four sites, even as it reported stellar second-quarter results that trounced Wall Street expectations.           

ISPE Hires Healthcare Association Exec as CEO

July 29, 2014 3:47 pm | News | Comments

ISPE has hired John Bournas as President and CEO, succeeding Nancy Berg who announced plans to leave the Society last fall. Mr. Bournas takes the helm at ISPE with extensive competencies in the healthcare association industry as well as significant international experience.

Allergan Reports Second Quarter 2014 Operating Results; Announces Layoffs

July 21, 2014 8:45 am | News | Comments

Allergan, Inc. announced operating results for the quarter ended June 30, 2014 and announced a restructuring that will eliminate 1500 jobs.                   

Aptuit Names Executive VP, Business Development & Marketing; Enhances Sterile Drug Product Capabilities

July 16, 2014 11:33 am | News | Comments

Aptuit LLC has appointed Paul D. Overton, Ph.D., as Executive Vice President, Business Development and Marketing, making him responsible for all of Aptuit’s sales and marketing activities.           

Bayer Names U.S. Head of Litigation

July 15, 2014 11:28 am | News | Comments

Bayer today announced the appointment of Malini Moorthy as Head of the Litigation Department in the United States, effective July 30.  She succeeds Kaspar Stoffelmayr, whose three-year assignment ended and has rejoined Bartlit Beck Herman Palenchar & Scott LLP.

Advertisement

Repligen Hires Chief Financial Officer

July 15, 2014 8:34 am | News | Comments

Repligen Corporation today announced that Jon K. Snodgres has been named its Chief Financial Officer. Mr. Snodgres joins Repligen from his CFO role at Maquet Cardiovascular, a medical device company.         

Merck KGaA’s Biopharmaceutical Division Appoints New Global Head of R&D

July 14, 2014 9:13 am | News | Comments

Merck KGaA’s biopharmaceutical division today announced the appointment of Luciano Rossetti, M.D., as Executive Vice President and Global Head of Research & Development as of July 21, 2014.          

China Indicts US, British Nationals Involved In GSK Investigation

July 13, 2014 11:26 pm | by The Associated Press | News | Comments

Chinese authorities formally indicted two corporate investigators, an American and Briton, for allegedly illegally obtaining and selling private information, state media reported Monday. Prosecutors in Shanghai filed charges against British investigator Peter Humphrey and his wife Yingzeng Yu, a U.S. citizen, at the city's No. 1 Intermediate People's Court, the official Xinhua News Agency said.

ScinoPharm President and CEO to Retire

July 11, 2014 8:04 am | News | Comments

ScinoPharm announced that after 17 years of dedicated service, its co-founder and President & CEO Dr. Jo Shen is retiring at the end of July 2014 and will be succeeded by Dr. Yung-Fa (Fred) Chen, currently Sr. Vice President of R&D and Chief Technology Officer, effective August 1, 2014.

Vertex Announces Retirement of Peter Mueller, Ph.D.

July 10, 2014 8:08 am | News | Comments

Vertex Pharmaceuticals Incorporated today announced that Peter Mueller, Ph.D., Executive Vice President of Global Research and Development and Chief Scientific Officer, will retire after more than 10 years with the company.      

Eisai Increases BELVIQ Sales Force by 50%

July 10, 2014 8:05 am | News | Comments

Arena Pharmaceuticals, reported that Eisai Inc. has completed its planned increase of more than 200 new contract sales representatives in its Metabolic Business Unit, increasing the sales force for BELVIQ by 50% to approximately 600.  

Ortho-Clinical Diagnostics Announces Executive Leadership Additions as It Becomes an Independent, Stand-Alone Company

July 8, 2014 8:58 am | News | Comments

Ortho-Clinical Diagnostics, Inc. unveiled its newly expanded executive leadership team following the acquisition of the company by The Carlyle Group from Johnson & Johnson.             

AAIPharma Services and Cambridge Major Laboratories Name New CEO

July 8, 2014 8:54 am | News | Comments

AAIPharma Services Corp., a global provider of pharmaceutical analytical testing, product development and manufacturing services, and Cambridge Major Laboratories, Inc., a provider pharmaceutical API development and manufacturingservices, announced the appointment of Stephan Kutzer, Ph.D. as Chief Executive Officer (CEO), effective August 1, 2014.

Actavis Closes $28B Forest Deal, Names New CEO

July 1, 2014 1:26 pm | by The Associated Press | News | Comments

Actavis has completed its $28 billion acquisition of fellow drugmaker Forest Laboratories, and the leader of the acquired company is now the CEO of Actavis.                

Alexza Promotes Edwin S. Kamemoto, Ph.D. to Senior Vice President, Regulatory Affairs

June 30, 2014 4:19 pm | News | Comments

Alexza Pharmaceuticals has announced the promotion of Edwin S. Kamemoto, Ph.D., to the newly created position of Senior Vice President, Regulatory Affairs.  Dr. Kamemoto will have primary responsibility for leading and directing all regulatory affairs and global pharmacovigilence activities.

Former Proctor & Gamble Exec to Head VA

June 30, 2014 7:54 am | by JULIE PACE, AP White House Correspondent | News | Comments

Seeking to turn around a troubled agency, President Barack Obama will nominate former Procter & Gamble executive Robert McDonald to lead a Veterans Affairs department gripped by reports of treatment delays and cover-ups.     

Tris Pharma Adds Chief Medical Officer and VP of Regulatory Affairs

June 26, 2014 8:06 am | News | Comments

Tris Pharma, a specialty pharmaceutical company focused on developing innovative technology-based products announced two key additions to its' executive team:  Sally A. Berry, MD, PhD  will join as Chief Medical Officer and Norma Cappetti will join as Vice President of Regulatory Affairs.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading